dysfunction due to glycogen-filled lysosomes has a significant role in the weakness observed in the tongue and diaphragm [2, 9, [14] [15] [16] [17] .
In 2015, Yang et al. was the first to report airway malacia (trachea-broncho-malacia) in a teenage female with Pompe disease. Despite receiving ERT for 8 years, she continued to experience declining pulmonary function. In an exploration to elucidate her deteriorating respiratory system, a bronchoscopy was performed. This revealed a decreased luminal airway diameter along her lower airways. The left bronchus was nearly occluded with 90% of the lumen collapsed, requiring a metal stent to be implanted [18] . Similar observations were noted in a teenage male receiving ERT who had a progressive obstructive airway and restrictive pulmonary disease. While undergoing anesthesia, the patient developed ventricular defibrillation leading to an emergency bronchoscopy. The bronchoscopy revealed a collapse of the lower trachea and bronchi, leading to an almost completely compressed left main bronchus [19] . The mechanism of tracheal and bronchial weakness was studied in the Pompe mouse model, where it was found that Pompe airways are hyporeponsive to bronchocontrictive agents, and reduced calcium signaling occurs in Pompe airway smooth muscle cells [19] . These functional findings are also likely the result of gross glycogen accumulation and enlarged lysosomes present in the smooth muscle layer of the trachea and bronchi [3, 20] .
In conclusion, we agree with the authors that glycogen accumulation in the diaphragm and intercostal muscles plays an integral role in respiratory dysfunction in Pompe disease. However, glycogen accumulation in the tongue, the respiratory motor neurons, and the airway smooth muscle are also important contributors to the Pompe disease respiratory morbidities and should not be overlooked.
